MSN Beats Allergan's Generic Patent Row In Bench Trial

By Adam Lidgett · September 28, 2023, 5:03 PM EDT

A Delaware federal judge has found numerous patents covering Allergan's bowel treatment drug Viberzi were invalid, handing a win to Sun Pharmaceutical Industries Ltd. and MSN Pharmaceuticals....

To view the full article, register now.

Documents

Case Information

Case Title

Allergan USA, Inc., et al. v. MSN Laboratories Private Limited, et al.

Case Number

1:19-cv-01727

Court

Delaware

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Date Filed

September 13, 2019